Pleural Effusions in Lung Cancer: Detection and Treatment-Reference-Cited by-同舟云学术

Pleural Effusions in Lung Cancer: Detection and Treatment

Published:2018-10-31 Issue: Volume: Page:
ISSN:
Container-title:Lung Cancer - Strategies for Diagnosis and Treatment
language:
Short-container-title:

Author:

Medenica Milic,Medenica Miras,Cosovic Danilo

Publisher

InTech

Link

http://www.intechopen.com/download/pdf/62305

Reference133 articles.

1. Taghizadeh N, Fortin M, Tremblay A. USA Hospitalizations for Malignant Pleural Effusions - Data from the National Inpatient Sample, 2012. Chest; Apr 2017;151(4):845-854

2. Rahman NM, Ali NJ, Brown G, et al. Local anaestetic thorascopy: British thoracic society pleural disease guidline, 2010. Thorax. 2010;65(Suppl 2):ii54-ii60

3. Johnston WW. The malignant pleural effusion: A review of cytopathlogical diagnoses of 584 specimens from 472 consecutive patients. Cancer. 1985;56:905-909

4. Chernow B, Sahn SA. Carcinomatous involvment of the pleura of 96 patients. The American Journal of Medicine. 1977;77:507-513

5. Naito T, Satoh H, Ishikawa H, et al. Pleural effusion as a significant prognostic factor in non small cell lung cancer. Anticancer Research. 1997;17:4743-4746

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression of cytokines in pleural effusions and corresponding cell lines of small cell lung cancer;Translational Lung Cancer Research;2024-01

2. Rapid diagnosis of malignant pleural mesothelioma and its discrimination from lung cancer and benign exudative effusions using blood serum;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2022-10

3. Tepotinib: Management of Adverse Events in Patients With MET Exon 14 Skipping Non-Small Cell Lung Cancer;Clinical Journal of Oncology Nursing;2022-10-01

4. Liquid biopsy using ascitic fluid and pleural effusion supernatants for genomic profiling in gastrointestinal and lung cancers;BMC Cancer;2022-09-27

5. Safety of Tepotinib in Patients With MET Exon 14 Skipping NSCLC and Recommendations for Management;Clinical Lung Cancer;2022-06